Clinical and Experimental Obstetrics & Gynecology (CEOG) is published by IMR Press from Volume 46 Issue 1 (2019). Previous articles were published by another publisher on a subscription basis, and they are hosted by IMR Press on imrpress.com as a courtesy and upon agreement with S.O.G.
Cite this article
Revisiting serum beta-human chorionic gonadotropin concentrations as a predictor for dizygotic twinning after in vitro fertilization
1 Department of Obstetrics and Gynecology, Faculty of Medicine, Akdeniz University, Antalya
2 Department of Obstetrics and Gynecology, Faculty of Medicine, Hacettepe University, Ankara
3 Department of Histology and Embryology, Faculty of Medicine, Hacettepe University, Ankara (Turkey)
Clin. Exp. Obstet. Gynecol. 2016, 43(4), 597–601; https://doi.org/10.12891/ceog3525.2016
Published: 10 August 2016
Purpose of investigation: To determine a cut-off value for beta-human chorionic gonadotropin (β-hCG) concentrations to predict dizygotic twinning after in vitro fertilization (IVF) and double embryo transfer (DET). Materials and Methods: This retrospective cohort study included 233 women who conceived after DET at IVF center, Hacettepe University Faculty of Medicine. Patients with serum β-hCG concentration ≥ 25 IU/l assayed on day 14 after oocyte retrieval were included into the study. Results: Lower serum β-hCG concentrations were observed in non-viable pregnancy when compared to their viable counterparts. In addition, twins exhibited higher β-hCG concentrations than singletons did. Receiver operator characteristic (ROC) curve analysis showed a significant relationship between serum β-hCG concentrations and the occurrence of twin pregnancy (area under the curve = 0.85, 95% confidence interval = 0.79–0.91, p < 0.001). For twin pregnancy, when β-hCG ≥ 175 IU/l, sensitivity was 77.3%, specificity was 80.0%, positive predictive value (PPV) was 48.2%, and negative predictive value (NPV) was 93.8%. Conclusion: β-hCG ≥ 175 IU/l might be used as a new cut-off value for early prediction of viable dizygotic twins following IVF-DET treatment cycles.
Beta-human chorionic gonadotropin
In vitro fertilization
Double embryo transfer